Dr. Lal Path Labs Ltd.
ISIN: INE600L01024 • Market Cap: ₹31,670 Cr
The 5-Pillar Quality Audit for Dr. Lal Path Labs Ltd.
Evaluated across Profitability, Financial Health, Historical Compounding, Valuation Safety, and Ownership Governance:
1. Profitability & Capital Efficiency
Weight: 25%Measures operating margins (29.0%), Return on Capital Employed (27.7%), and equity compounding (20.1%).
2. Financial Health & Solvency
Weight: 25%Debt-to-Equity is 0.00 with comfortable interest coverage and clean working capital.
3. Growth & Compounding Track Record
Weight: 20%Historical 3Y Sales CAGR (9.1%) and 3Y PAT CAGR (15.2%).
4. Valuation Multiple & Margin of Safety
Weight: 15%Trades at P/E of 58.44 vs PEG of 5.26 and Dividend Yield of 1.1%.
5. Ownership Quality & Governance
Weight: 15%Promoter holding stands at 53.2%, backed by 38.8% institutional ownership.
Key Fundamental Strengths
Superior Capital Efficiency (ROCE: 27.7%)
Dr. Lal Path Labs Ltd. generates exceptional return on capital employed of 27.7%, reflecting pricing power and competitive moat.
Robust Equity Compounding (ROE: 20.1%)
Shareholder equity compounds at a healthy 20.1%, exceeding average Indian equity benchmarks.
Fortress Balance Sheet (D/E: 0.00)
The company operates virtually debt-free, shielding net margins from interest rate cycles and monetary tightening.
Deep Institutional Sponsorship (38.8%)
Mutual funds, domestic DIIs, and foreign FIIs hold 38.8%, providing strong governance scrutiny.
Areas to Watch & Potential Risks
Sectoral & Macro Headwinds (Healthcare)
Subject to broader cyclical demand, raw material price shifts, and regulatory frameworks governing the Healthcare space.
Quantitative Strategy Eligibility
Checking LALPATHLAB against established Indian wealth creation frameworks:
Coffee Can Investing Framework
Fails 10%+ revenue growth or 15%+ minimum capital return benchmark over historical periods.
Quality Factor Screener (High RoIC + Low Debt)
Qualifies for Indian Quality Indices with overall score of 76/100 and clean gearing.
GARP / Value-Growth Blend
Valuation multiple or return metrics require further cyclical pullback.
Healthcare Sector Peer Comparison
Compare LALPATHLAB directly against top industry peers by market capitalization:
| Company | 5-Pillar Score | Market Cap | P/E | ROCE | D/E | Scorecard |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs Ltd. (LALPATHLAB)Current | 76/100 | ₹31,670 Cr | 58.44 | 27.7% | 0.00 | — |
| Sun Pharmaceutical Industries Ltd. (SUNPHARMA) | 77/100 | ₹4.55 Lakh Cr | 37.65 | 20.4% | 0.05 | View |
| Divi's Laboratories Ltd. (DIVISLAB) | 73/100 | ₹2.26 Lakh Cr | 77.37 | 19.4% | 0.00 | View |
| Torrent Pharmaceuticals Ltd. (TORNTPHARM) | 64/100 | ₹1.91 Lakh Cr | 87.43 | 9.5% | 1.76 | View |
| Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) | 70/100 | ₹1.27 Lakh Cr | 60.55 | 19.1% | 0.62 | View |
| Cipla Ltd. (CIPLA) | 63/100 | ₹1.14 Lakh Cr | 33.94 | 16.1% | 0.01 | View |
Frequently Asked Questions: Dr. Lal Path Labs Ltd.
Q:What is the 5-Pillar Fundamental Score for Dr. Lal Path Labs Ltd. (LALPATHLAB)?
Dr. Lal Path Labs Ltd. has a RupeeTools Fundamental Score of 76/100, placing it in the 'Solid & Healthy' category. Its pillar scores are: Profitability (92/100), Financial Health (86/100), Growth (62/100), Valuation (43/100), and Ownership Quality (85/100).
Q:Is LALPATHLAB fundamentally strong for long-term investment?
Yes, LALPATHLAB exhibits solid fundamental strength with a 76/100 score, driven by a return on equity of 20.1% and a debt-to-equity ratio of 0.00.
Q:Does LALPATHLAB pass the Coffee Can Investing filter?
No. LALPATHLAB does not currently meet the strict 15% ROCE and 10% sustained topline compounding threshold mandated by the Coffee Can investing framework.
Q:How does LALPATHLAB compare against other Healthcare peers?
Within India's Healthcare sector, LALPATHLAB trades at a P/E of 58.44 and generates an ROCE of 27.7%. Compare its 5-Pillar score of 76/100 against top sector peers like Sun Pharmaceutical Industries Ltd. (77/100), Divi's Laboratories Ltd. (73/100).
Regulatory & SEBI Research Analyst Compliance Disclaimer:
This 5-pillar fundamental score is an automated quantitative health check generated purely from historical public financial statements, corporate filings, and exchange disclosures for educational and informational purposes only. It does NOT constitute investment advice, a stock recommendation, or a solicitation to buy or sell securities. RupeeTools is not a SEBI-registered Research Analyst. Please consult a SEBI-registered financial advisor before making investment decisions.